PCI Issues Special Inspection Guidelines for 2025-2026 academic session Written By Dr. Divya Colin14 April 2025 6:15 PM ISTNew Delhi: The Pharmacy Council of India (PCI) has recently issued a circular providing special guidelines for approved inspectors and pharmacy...
Pfizer discontinues development of danuglipron for chronic weight management Written By Ruchika Sharma14 April 2025 5:41 PM ISTNew York: Pfizer Inc. has announced the company has discontinued the development of danuglipron (PF-06882961), an oral glucagon-like...
Multi-drug resistant infections medicine 'Zaynich' to get USFDA approval next year: Wockhardt Chairman Written By Ruchika Sharma14 April 2025 3:49 PM ISTDubai: Zaynich, a multi-drug resistant infections medicine, is set to receive the US Food and Drug Administration (USFDA) approval in 2026,...
Arthritis drug: Sandoz files US antitrust litigation against Amgen Written By Ruchika Sharma14 April 2025 2:30 PM ISTSandoz is seeking an injunction to prevent Amgen from using certain patent rights to block biosimilar competition and allow Sandoz to launch Erelzi.
Sun Pharma, Zydus and Glenmark recall various products in US over manufacturing issues Written By Ruchika Sharma14 April 2025 1:30 PM ISTSun Pharma, Zydus, and Glenmark are recalling various products in the US market due to manufacturing-related concerns, the US health regulator...
Roche Columvi gets European Commission nod as bispecific antibody for diffuse large B-cell lymphoma after initial therapy Written By Ruchika Sharma14 April 2025 12:30 PM ISTBasel: Roche has announced that the company has received approval from the European Commission for Columvi (glofitamab) in...
Aurobindo Pharma gets USFDA final, tentative nod for different strengths of deep vein thrombosis drug Rivaroxaban Written By Ruchika Sharma14 April 2025 11:30 AM ISTAurobindo Pharma Limited has announced that it has received final approval from the US Food & Drug Administration (USFDA) to manufacture and...
Zydus Healthcare gets CDSCO Panel nod to conduct Phase III CT of Glycopyrrolate plus Indacaterol Metered Dose Inhalation Written By Dr. Divya Colin13 April 2025 6:15 PM ISTNew Delhi: The Subject Expert Committee (SEC), functional under the Central Drug Standard Control Organization (CDSCO), has granted approval to Zydus...
AstraZeneca Gets CDSCO Panel Nod To study Tezepelumab Written By Dr. Divya Colin13 April 2025 5:30 PM ISTNew Delhi: Pharmaceutical major AstraZeneca Pharma India has got approval from the Subject Expert Committee (SEC) functional under the Central Drug...
US tariffs on pharma sector would be counterproductive for Americans, says Wockhardt Chairman Ruchika Sharma13 April 2025 3:15 PM ISTWockhardt Chairman Habib Khorakiwala said that U.S. tariffs on pharmaceutical products would ultimately be counterproductive for Americans.The U.S....
Novartis plans to invest USD 23 billion over next 5 years in US based infrastructure Ruchika Sharma13 April 2025 12:30 PM ISTEast Hanover: Novartis, a global medicines company, has announced a planned USD 23 billion investment over 5 years in US-based infrastructure,...
Pomalyst monopoly case: Bristol Myers wins dismissal of lawsuit Written By Ruchika Sharma13 April 2025 11:00 AM ISTA federal judge in New York has dismissed a proposed class action against pharmaceutical giant Bristol Myers Squibb, which accused the company of...
